Murray B. Gordon

2.0k total citations
59 papers, 1.2k citations indexed

About

Murray B. Gordon is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Murray B. Gordon has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Murray B. Gordon's work include Growth Hormone and Insulin-like Growth Factors (41 papers), Pituitary Gland Disorders and Treatments (40 papers) and Adrenal and Paraganglionic Tumors (11 papers). Murray B. Gordon is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (41 papers), Pituitary Gland Disorders and Treatments (40 papers) and Adrenal and Paraganglionic Tumors (11 papers). Murray B. Gordon collaborates with scholars based in United States, Germany and Netherlands. Murray B. Gordon's co-authors include Peter G. Bullough, Michael S. Gordon, Beverly M. K. Biller, Mark E. Molitch, P R Larsen, Jack L. Leonard, Frank R. Crantz, Maria Fleseriu, W.H. Ludlam and Kevin C.J. Yuen and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Murray B. Gordon

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray B. Gordon United States 20 764 357 162 119 108 59 1.2k
Joachim Feldkamp Germany 21 799 1.0× 216 0.6× 151 0.9× 203 1.7× 217 2.0× 75 1.3k
Jens Bollerslev Norway 21 1.2k 1.6× 494 1.4× 363 2.2× 266 2.2× 203 1.9× 47 1.7k
Jakob Dal Denmark 14 528 0.7× 219 0.6× 65 0.4× 128 1.1× 74 0.7× 37 741
Emiliano A. Palmieri Italy 19 1.1k 1.4× 231 0.6× 100 0.6× 475 4.0× 130 1.2× 33 1.6k
M Ventz Germany 17 1.2k 1.6× 305 0.9× 71 0.4× 240 2.0× 53 0.5× 39 1.5k
Loredana De Pasquale Italy 13 160 0.2× 212 0.6× 53 0.3× 272 2.3× 42 0.4× 35 722
P Muona Finland 14 288 0.4× 296 0.8× 66 0.4× 101 0.8× 49 0.5× 18 872
Mara Boschetti Italy 18 487 0.6× 143 0.4× 276 1.7× 116 1.0× 132 1.2× 56 884
Gaia Tabacco Italy 18 252 0.3× 465 1.3× 55 0.3× 185 1.6× 100 0.9× 52 982
Lars Rolighed Denmark 24 330 0.4× 668 1.9× 91 0.6× 334 2.8× 364 3.4× 71 1.7k

Countries citing papers authored by Murray B. Gordon

Since Specialization
Citations

This map shows the geographic impact of Murray B. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray B. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray B. Gordon more than expected).

Fields of papers citing papers by Murray B. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray B. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray B. Gordon. The network helps show where Murray B. Gordon may publish in the future.

Co-authorship network of co-authors of Murray B. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Murray B. Gordon. A scholar is included among the top collaborators of Murray B. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray B. Gordon. Murray B. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Geer, Eliza B., Wenyu Huang, Murray B. Gordon, et al.. (2023). SAT622 Matched Physician- And Patient-reported Responses Of Acromegaly Symptom Control: Comparisons From The Macro Registry. Journal of the Endocrine Society. 7(Supplement_1).
3.
Ferone, Diego, Pamela U. Freda, Laurence Katznelson, et al.. (2023). THU070 Randomized, Placebo-controlled Phase 3 Trial Protocol Assessing The Efficacy And Safety Of Octreotide Subcutaneous Depot (CAM2029) In Patients With Acromegaly. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
4.
Gadelha, Mônica R., Murray B. Gordon, Mirjana Doknić, et al.. (2022). ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 108(5). e148–e159. 19 indexed citations
5.
Nachtigall, Lisa B., Maria Fleseriu, Murray B. Gordon, et al.. (2021). Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results. Pituitary. 24(6). 943–953. 15 indexed citations
6.
Pivonello, Rosario, Irina Bancos, Richard A. Feelders, et al.. (2021). Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. Frontiers in Endocrinology. 12. 662865–662865. 44 indexed citations
7.
Fleseriu, Maria, Mark E. Molitch, Alexander Dreval, et al.. (2021). Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands. Frontiers in Endocrinology. 12. 627711–627711. 21 indexed citations
8.
Brown, David R., Honey E. East, Murray B. Gordon, et al.. (2020). Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations. SHILAP Revista de lepidopterología. 6(1). 18–18. 21 indexed citations
9.
10.
Weber, Matthias M., Murray B. Gordon, Charlotte Höybye, et al.. (2019). Growth hormone replacement in adults: Real-world data from two large studies in US and Europe. Growth Hormone & IGF Research. 50. 71–82. 11 indexed citations
11.
Woodmansee, Whitney W., Murray B. Gordon, Mark E. Molitch, et al.. (2018). Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis. Endocrine. 61(1). 105–117. 5 indexed citations
12.
Geer, Eliza B., Alejandro Ayala, Vivien Bonert, et al.. (2017). Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary clinicians. Pituitary. 20(4). 422–429. 7 indexed citations
13.
Salvatori, Roberto, Murray B. Gordon, Whitney W. Woodmansee, et al.. (2017). A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry. Pituitary. 20(6). 605–618. 9 indexed citations
14.
Gordon, Michael S., et al.. (2016). Occult Langerhans Cell Histiocytosis Presenting with Papillary Thyroid Carcinoma, a Thickened Pituitary Stalk and Diabetes Insipidus. Case Reports in Endocrinology. 2016. 1–3. 10 indexed citations
15.
Freda, Pamela U., Murray B. Gordon, Nicky Kelepouris, et al.. (2014). Long-Term Treatment with Pegvisomant as Monotherapy in Patients with Acromegaly: Experience from Acrostudy. Endocrine Practice. 21(3). 264–274. 59 indexed citations
16.
Salvatori, Roberto, Whitney W. Woodmansee, Mark E. Molitch, Murray B. Gordon, & Kathleen G. Lomax. (2013). Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry. Pituitary. 17(1). 13–21. 42 indexed citations
17.
Yuen, Kevin C.J., Beverly M. K. Biller, Laurence Katznelson, et al.. (2012). Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Pituitary. 16(2). 220–230. 36 indexed citations
18.
Gordon, Michael S., et al.. (2005). Abnormal prorenin processing in growth hormone deficiency. Growth Hormone & IGF Research. 15(4). 251–255. 1 indexed citations
19.
Gordon, Murray B., et al.. (1999). Variations In Adequate Levothyroxine Replacement Therapy In Patients With Different Causes Of Hypothyroidism. Endocrine Practice. 5(5). 233–238. 51 indexed citations
20.
Gordon, Michael S., et al.. (1997). Sodium balance modulates thirst in normal man. Endocrine Research. 23(4). 377–392. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joachim Feldkamp Breakdown of academic impact, for papers by Jens Bollerslev Breakdown of academic impact, for papers by Jakob Dal Breakdown of academic impact, for papers by Emiliano A. Palmieri Breakdown of academic impact, for papers by M Ventz Breakdown of academic impact, for papers by Loredana De Pasquale Breakdown of academic impact, for papers by P Muona Breakdown of academic impact, for papers by Mara Boschetti Breakdown of academic impact, for papers by Gaia Tabacco Breakdown of academic impact, for papers by Lars Rolighed
Rankless by CCL
2026